AstraZeneca scored a ‘yes’ vote at yesterday’s FDA advisory panel meeting. The agency’s expert advisors recommended

Array BioPharma Inc. (Nasdaq: ARRY) and Amgen Inc.(Nasdaq: AMGN) today announced that they entered into an agreement granting Amgen exclusive worldwide rights to Array’s small-molecule glucokinase activator program, including ARRY-403, currently being tested in a Phase 1 clinical trial in patients with Type 2 diabetes.

Original Source of Array BioPharma…

Takeda Pharmaceutical Company Limited (“Takeda”) and Pfizer Inc. (“Pfizer”) announced that they have entered into an agreement under which Pfizer in China will co-promote Takeda’s Actos® (pioglitazone HCl) with Tianjin Takeda Pharmaceuticals in China.

Original Source of Takeda and Pfizer to Co-Promote Takeda’s Actos® for the Treatment of Type 2…

Sanofi-Aventis is recalling some 800,000 pediatric doses of H1N1 vaccine because tests showed some batches weren’t potent enough, the Centers for Disease Control and Prevention said. The CDC said the shots’ potency was “only slightly below the ‘specified’ range” and that there were no safety concerns, the Wall Street…

Sanofi-Aventis is plotting a new marketing push into India. Dubbed “Prayas,” the effort aims to boost generic drug sales in small towns and across rural India, the Business Standard reports. The plan is to hire four contract manufacturers to turn out off-patent meds, aiming for 15 new generic products…

As rumored last month, French executive Serge Weinberg is set to join the Sanofi-Aventis board as non-executive chairman, Paris newspapers are reporting. Report

Original Source of Ex-PPR chief Weinberg tapped as Sanofi chair

Eli Lilly won FDA approval for its long-lasting injectable version of Zyprexa, the blockbuster antipsychotic. Dubbed Zyprexa Relprevv, the injection sustains delivery for up to four weeks, the company said, basing its application for approval on a 2,054-patient study. The drug got FDA’s nod after Lilly developed a risk-management…

Pfizer taketh away earlier this year, when it slashed its dividend in half

More proof that China’s where it’s at for pharma reps. Japan’s Takeda Pharmaceutical has brought Pfizer on board to help market its blockbuster diabetes drug Actos there, aiming for its fast-growing market for diabetes meds. China is expected to have more than 50 million diabetics by 2025, Pfizer said…

Abbott (NYSE: ABT) announced today a definitive agreement to acquire STARLIMS Technologies Ltd. (Nasdaq: LIMS), a leading provider of laboratory information management systems, for approximately $123 million in cash. The acquisition strengthens Abbott’s competitive position in the global diagnostics market, providing advanced web-based applications to help laboratories efficiently store, retrieve…